Ascendis Pharma Grants 14,060 Employee Warrants at $265.57 Exercise Price

Key Highlights

• Ascendis Pharma's board granted 14,060 warrants to employees on July 14, 2026.
• Each warrant has an exercise price of $265.57 per share, matching the closing price on the grant date.
• Warrants vest 25% on the one-year anniversary of the grant date.
• The remaining 75% vests at a rate of 1/36th per month thereafter, subject to continued service.
• After this grant, 1,539,503 additional warrants remain available for future grants.
• The company amended its Articles of Association to provide for the grant of these Warrants.